Platelet aggregation rate - Globe Thesis

Keyword [Platelet aggregation rate] Result: 41 - 60 \| Page: 3 of 5
41.	CYP2C19 Gene Polymorphism And Steady-state Plasma Concentration Of Correlation Between Clopidogrel Resistance
42.	Preventive Effect Of Danhong Huayu Koufuye Combined With Metformin On Diabetic Retinopathy In Zucker Diabetic Fatty Rats
43.	The Risk Evaluation Of Readmission Of Acute Ischemic Stroke And Transient Ischemic Attack
44.	Effects Of Three Peptides KM-5?13?14 On Platelet Aggregation And Activation Function
45.	Effect Of Aspirin Combined Clopidogrel And Aspirin Combined Dipyridamole On Platelet Function In The Treatment Of Arteriosclerosis Obliterans
46.	Study Of Association Of Platelet Function "Anti Jump" And Ischemic Stroke After Stop Taking Clopidogrel
47.	Correlation Between CYP2C19 Genotype And Platelet Aggregation Rates Detected By Light Transmittance Aggregometry In Patients With Coronary Heart Disease
48.	The Study Of Antiplatelet Effects Of Compound Danshen Dropping Pills For Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention On Different Constitution Of Traditional Chinese Medicine
49.	Study The Safety And Effectiveness Of Doxofylline In The Treatment Of Dyspnea Associated With Ticagrelor
50.	Clinical Efficacy And Quality Of Life Observation Of Ticagrelor In Acute Coronary Syndrome Patients With Percutaneous Coronary Intervention
51.	Efficacy Of Ticagrelor In Patients With Acute ST Segment Elevation Myocardial Infarction And Type 2 Diabetes Mellitus After Primary Percutaneous Coronary Intervention
52.	The Study On The Platelets High Reactivity In Patients With ST-segment Elevation Myocardial Infarction After Treatment With Ticagrelor
53.	To Study The Relationship Between CYP2C19 Gene Polymorphism And Platelet Aggregation Rate In Patients With Coronary Heart Disease
54.	Comparison Of Effects Of Chronic Intermittent Hypoxia And Chronic Continuous Hypoxia On Vascular Endothelial Function And Myocardial Contractility
55.	Analysis Of CYP2C19 Polymorphism In Patients With Poor Inhibition Of Platelet Aggregating Function
56.	Analysis On The Effectiveness Of Ticagerlor In Patients With Acute Coronary Syndrome
57.	Correlation Between Platelet Function Test And Dual Antiplatelet Therapy In Patients With Non-ST-segment Elevation Acute Coronary Syndrome
58.	The Efficacy And Safety Of Ticagrelor Reduction Under The Guidance Of Platelet Aggregation Rate
59.	The Retrospective Analysis Of The Related Influencing Factors On Platelet Aggregation Rate
60.	Changes And Clinical Significance Of Platelet Aggregation Rate,Plasma Fibrinogen And D-dimer In Pregnant Women With Gestational Diabetes Mellitus
<<First <Prev Next> Last>> Jump to